BAC-PE Financial Statements & Analysis
Complete financial statements for BAC-PE including income statement, balance sheet, and cash flow statement. Analyze BAC-PE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-0.5% ↓
Net Income
12.4% ↑
Gross Margin
12.3% ↑
Operating Margin
29.4% ↑
Balance Sheet
Current Ratio
36.9% ↑
Debt to Equity
-45.8% ↑
Asset Turnover
-4.8% ↓
Cash Flow
Operating Cash Flow
243.2% ↑
Net Cash Flow
-35.6% ↓
Free Cash Flow
243.2% ↑
Cash Flow to Debt
357.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 192.43B | 191.57B | 0.5% | |
| Gross Profit | 96.07B | 107.42B | 11.8% | |
| Operating Income | 29.25B | 37.70B | 28.9% | |
| Net Income | 27.13B | 30.51B | 12.4% | |
| EPS | 3.25 | 3.88 | 19.4% | |
| EBITDA | 31.44B | 40.01B | 27.2% | |
| Gross Margin | 49.92% | 56.08% | 12.3% | |
| Operating Margin | 15.20% | 19.68% | 29.4% | |
| Net Income Margin | 14.10% | 15.93% | 13.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 191.57B | 192.43B | 171.91B | — | — |
| Gross Profit | 107.42B | 96.07B | 94.19B | — | — |
| Operating Income | 37.70B | 29.25B | 28.34B | — | — |
| Net Income | 30.51B | 27.13B | 26.52B | — | — |
| EPS | 3.88 | 3.25 | 3.10 | — | — |
| EBITDA | 40.01B | 31.44B | 30.40B | — | — |
| Gross Margin | 56.08% | 49.92% | 54.79% | — | — |
| Operating Margin | 19.68% | 15.20% | 16.49% | — | — |
| Net Income Margin | 15.93% | 14.10% | 15.42% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into BAC-PE's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics